|

COPD Clinical Trials in Texas

22 recruiting studies across 7 cities

Browse by City

Houston
17 trials
Arlington
15 trials
Dallas
15 trials
Fort Worth
12 trials
San Antonio
9 trials
El Paso
6 trials
Austin
2 trials

All Trials in Texas

Phase
Trial Phase Dist.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypePhase 3<1 mi
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePhase 3<1 mi
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Phase 3<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Phase 3<1 mi
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THSN/A<1 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPDPhase 2<1 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseasePhase 2<1 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypePhase 3<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)Phase 3<1 mi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)Phase 2<1 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseasePhase 2/3<1 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Phase 3<1 mi
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3N/A<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDPhase 2<1 mi
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeN/A<1 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening—<1 mi
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe EmphysemaN/A<1 mi
STRIVE Post-Market Registry Study—<1 mi
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer—<1 mi
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of TreatmentPhase 228 mi
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive DiseasePhase 129 mi
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)Phase 231 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.